Sonora Investment Management’s PHARMOS CORP NEW PARS Stock Holding History
Bought
Maintained
Sold
Sonora Investment Management's PARS Position: Q4 2016 in Review
Sonora Investment Management sold out of PHARMOS CORP NEW (PARS) in Q4 2016, closing a stake of 1,000 shares — an estimated $12 sold.
Sonora Investment Management first reported a position in PARS in Q3 2016 and held it in 1 quarter. The position peaked at $12 in Q3 2016. 0 funds tracked by Wall St. Rank hold PARS as of Q4 2016.
- Sonora Investment Management reported no remaining PHARMOS CORP NEW position as of Q4 2016 after selling out during the quarter.
- Sonora Investment Management sold 1,000 PHARMOS CORP NEW shares in Q4 2016, an estimated $12.
- Sonora Investment Management first reported a position in PHARMOS CORP NEW in Q3 2016 and held it in 1 quarter.
- Sonora Investment Management's PHARMOS CORP NEW position peaked at $12 in Q3 2016.
- 0 funds tracked by Wall St. Rank held PHARMOS CORP NEW as of Q4 2016.
Based on Sonora Investment Management's 13F filing for Q4 2016, filed 12 Jan 2017.